RedHill revenues up 31 percent in Q4
RedHill Biopharma's revenues continue to climb after starting U.S. promotional activities for two gastrointestinal products in June and September. That's as the Tel-Aviv, Israel-based company continues to build up its U.S. commercial operations based in Raleigh.
Net revenues were $2 million for the fourth quarter of 2017, up 31 percent over the third quarter, RedHill (Nasdaq: RDHL) reported Monday. The company stated that it “expects cont inued quarter over quarter net revenue growth.”
As…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Jennifer Henderson Source Type: news
More News: American Health | Gastroenterology | Health Management | Israel Health | Middle East Health